AngioDynamics (NASDAQ:ANGO) focuses on developing innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease, and oncology. AngioDynamics is committed to improving patient outcomes by providing healthcare professionals with state-of-the-art products that support a wide range of medical procedures. Their portfolio includes a broad range of devices, including catheters, port systems, and microwave ablation systems, designed to make procedures more efficient and reduce recovery times. By continuously investing in research and development, AngioDynamics aims to advance its technologies and expand its product offerings to meet the evolving needs of the healthcare industry. Their objective is not only to lead in the markets they serve but also to provide solutions that deliver superior clinical results and economic value to healthcare providers and patients alike.